Seroba Life Sciences

Seroba Life Sciences is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech. They aim to help entrepreneurs create and build world-class businesses around extraordinary science. The firm emphasizes making an impact and working together with its portfolio companies. Their investment strategy appears to center on identifying and supporting companies with promising innovations in both therapeutics and medical devices within the European life sciences sector. Seroba invests in companies developing next-generation therapeutics and medical devices, as evidenced by their portfolio companies, Alveus Therapeutics, Azafaros, ShiraTronics, and Ryme Medical. The firm is involved from early stages supporting the scaling and expansion of the portfolio companies, exemplified in Deciphex securing venture debt funding to accelerate their growth. Their investment thesis is also validated by the firm's involvement in industry discussions and publications. Seroba, along with BGV and Hadean, led the development of Invest Europe's position paper on "Biotech and Healthcare: The Venture Capital and Private Equity Perspective." Overall, Seroba invests in and supports companies that are developing next-generation therapies and medical devices. The firm looks to help its portfolio companies develop and become sustainable businesses that will make a difference in the market. The firm seems to provide significant backing to companies and help them take the next steps in their business development.